Answers are grounded in this paper and cite their sources.
Serotonin receptor 5-HT7 and tropomyosin receptor kinase B (TrkB) are both key regulators of neuroplasticity implicated in the pathophysiology and treatment of depression. Although functional crosstalk between these receptors has been suggested, the underlying molecular mechanism remains unknown. Here, we investigated the physical and functional interaction between 5-HT7 and TrkB receptors at behavioral, biochemical, and molecular levels. Using males of the antidepressant-sensitive cataleptic (ASC) mouse model of depressive-like behavior, we demonstrated that repeated (9 days) activation of 5-HT7 receptors with the selective agonist LP-211 produced antidepressant-like effects in the sucrose preference test. These behavioral effects were dependent on TrkB signaling, as it was prevented by pretreatment with the TrkB antagonist ANA12. Both acute and repeated 5-HT7 receptor activation increased TrkB phosphorylation in the mouse brain, although this long-term effect was brain region- and amino acid residue-specific. To determine if these functional interactions were mediated by a direct physical association, we used co-immunoprecipitation and FRET assays. We found that 5-HT7 and TrkB form heteroreceptor complexes in vitro in neuroblastoma cells and in vivo in the mouse frontal cortex, hippocampus, and midbrain. Collectively, our findings support an oligomerization between 5-HT7 and TrkB receptors and suggest that this association may contribute to the antidepressant-like effects of 5-HT7 receptor activation.
No takes yet. Share an insight, caveat, or question.
Ilchibaeva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: